Last updated on March 2019

Clostridium Difficile Vaccine Efficacy Trial


Brief description of study

The Clover trial is evaluating an investigational vaccine that may help to prevent Clostridium difficile infection. Participants in the study are adults 60 years of age and older, who are at risk of developing Clostridium difficile infection. The study will assess whether the vaccine prevents the disease, and whether it is safe and well tolerated. Each subject will receive 3 doses of Clostridium difficile vaccine or placebo and be followed for up to 3 years after vaccination for potential Clostridium difficile infection.

Detailed Study Description

Clostridium Difficile

Clinical Study Identifier: NCT03090191

Contact Investigators or Research Sites near you

Start Over

Sekino Hospital

Toshima-ku, Japan
0.93miles
  Connect »

Nerima General Hospital

Nerima-ku, Japan
2.28miles
  Connect »

Fukuwa Clinic

Tokyo, Japan
4.48miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.